During the past decade, Hawaii Cancer Care Inc - Waterfront Plaza conducted 139 clinical trials. In the 10-year time frame, 139 clinical trials started and 81 clinical trials were completed, i.e. on average, 58.3% percent of trials that started reached the finish line to date. In the past 5 years, 57 clinical trials started and 59 clinical trials were completed. i.e. 103.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hawaii Cancer Care Inc - Waterfront Plaza" #1 sponsor was "National Cancer Institute (NCI)" with 102 trials, followed by "SWOG Cancer Research Network" with 38 trials sponsored, "Alliance for Clinical Trials in Oncology" with 21 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 10 trials sponsored and "NRG Oncology" with 10 trials sponsored. Other sponsors include 8 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hawaii Cancer Care Inc - Waterfront Plaza" #1 collaborator was "National Cancer Institute (NCI)" with 88 trials as a collaborator, "NRG Oncology" with 23 trials as a collaborator, "Canadian Cancer Trials Group" with 8 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator and "NCIC Clinical Trials Group" with 3 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Hawaii Cancer Care Inc - Waterfront Plaza" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Lung Cancer AJCC v8" (9 trials), "Recurrent Breast Carcinoma" (8 trials), "Stage IV Breast Cancer AJCC v6 and v7" (8 trials) and "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials). Many other conditions were trialed in "Hawaii Cancer Care Inc - Waterfront Plaza" in a lesser frequency.

Most popular intervention types in "Hawaii Cancer Care Inc - Waterfront Plaza" are "Drug" (150 trials), "Other" (133 trials), "Biological" (76 trials), "Procedure" (47 trials) and "Radiation" (28 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (71 trials), "Quality-of-Life Assessment" (56 trials), "Questionnaire Administration" (37 trials), "Computed Tomography" (24 trials) and "Carboplatin" (23 trials). Other intervention names were less common.

The vast majority of trials in "Hawaii Cancer Care Inc - Waterfront Plaza" are 148 trials for "All" genders, 35 trials for "Female" genders and 7 trials for "Male" genders.

Currently, there are NaN active trials in "Hawaii Cancer Care Inc - Waterfront Plaza". undefined are not yet recruiting, 44 are recruiting, 100 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Hawaii Cancer Care Inc - Waterfront Plaza, 6 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Hawaii Cancer Care Inc - Waterfront Plaza, 8 "Phase 1" clinical trials were conducted, 92 "Phase 2" clinical trials and 103 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".